Results 191 to 200 of about 660,646 (336)

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

Prediction of Cardiogenic Shock in Acute Myocardial Infarction Patients Using a Nomogram. [PDF]

J Clin Med
Wang J, Zhao C, Yang C, Dong Y, Yang X, Sun C.   +5 more
europepmc   +1 more source

A case report of left atrial myxoma-induced acute myocardial infarction and successive stroke

, 2018
Qiushuang Wang, Feifei Yang, Fei Zhu, Cunshan Yao   +3 more
openalex   +1 more source

Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction. [PDF]

, 1997
Satoshi Hirohata, Shozo Kusachi, Masaaki Murakami, T. Murakami, Ikuo Sano, Tomoko Watanabe, Issei Komatsubara, Junichi Kondo, Toshio Tsuji   +8 more
openalex   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Sex differences in acute myocardial infarction: protocol for an umbrella review. [PDF]

BMJ Open
Tørris C, Bjørnnes AK, Hagen MC, Halvorsen S, Jernberg T, Lie I.   +5 more
europepmc   +1 more source

Acute Right Ventricular Myocardial Infarction: A Very Specific Entity

, 2007
Goran Koraćević
openalex   +2 more sources

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Dynamic Regulation of Macrophage Polarization in Acute Myocardial Infarction and Its Therapeutic Potential. [PDF]

J Inflamm Res
Xu A, Xu S, Tan X, Sun Q, Song Y, Nong Y, Wang X, Zeng Y, Fan H, Zhou Y.   +9 more
europepmc   +1 more source